MAIA Biotechnology Other Current Assets

The latest other current assets for MAIA is $640K as of June 2026. That compares with $820K in the prior-year period — down 21.4% year over year. Investors often review this figure alongside MAIA Biotechnology's historical trend and sector peers before judging valuation or financial health.

Over the past year, MAIA's other current assets moved from $820K to $640K — a 21.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MAIA Biotechnology's operating scale or balance-sheet position.

A other current assets figure of $640K for MAIA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MAIA's other current assets ($640K), review year-over-year change from $820K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.